Long intergenic non-protein coding RNA 2662 (LINC02662)

Long intergenic non-protein coding RNA 2662 (LINC02662) is a member of the long intergenic non-coding RNA (lincRNA) subclass of long non-coding RNAs (lncRNAs). LincRNAs are defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap with annotated protein-coding genes[1][5]. They are typically transcribed by RNA polymerase II and undergo capping, splicing, and poly-adenylation, although these processes may differ in detail compared to mRNAs[1]. LincRNAs play diverse regulatory roles in fine-tuning gene expression, modifying chromatin states, stabilizing RNA, and influencing transcription—often with tissue specificity and through both cis- and trans-acting mechanisms[1][5]. While some lincRNAs are well-studied in disease contexts such as cancer, the specific biological function and disease relevance of LINC02662 itself have not been established in the current literature. There are no known drugs that directly target this RNA, and it is generally not considered a primary therapeutic target in its own right[1][5].

Other names

LINC02662